AI companies such as OpenAI and Anthropic have long focused on building tools that can write code that will speed up software ...

2025 has come and gone. It was an interesting year and had its fair share of weird Vancouver stories. We’ve gone through some ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Nuclear fusion. People on Mars. Artificial general intelligence. These are just some of the advances that could come by the ...

The rise of artificial intelligence has affected many facets of society, including education. Writer Abby Moore explores how ...

The obvious culprit is the artificial intelligence boom that has upended the tech industry, birthing a fresh glossary of ...

WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

A professor who refused to bow to activist progressives and parrot land acknowledgements has scored a major First Amendment legal victory — after a years-long battle. “I’m not going to be silenced.

Neuroscientist Steve Ramirez has found ways to plant memories in mice. Here's what that could mean for humans.

ScienceDaily features breaking news about the latest discoveries in science, health, the environment, technology, and more -- from leading universities, scientific journals, and research organizations ...

Governments and tech companies continue to pour money into quantum technology in the hopes of building a supercomputer that can work at speeds we can't yet fathom to solve big problems.